Understanding Candida albicans to Develop More Effective Antifungal Products

Our bodies are inhabited by millions of microorganisms known as microflora. The microflora in our bodies can be beneficial but may also become harmful under abnormal conditions, leading to various infections. Candidiasis is one such opportunistic infection caused by Candida yeast. This infection usually affects individuals with weakened immune systems. 

The yeast is part of the normal microflora naturally found in the human body. Candida can grow in several areas of the body, such as the oral cavity, gastrointestinal tract, genital organs, and other parts. Under normal conditions, its growth is controlled by the immune system and the balance of the body’s microbiota. 

However, it can become pathogenic when there is a disruption in microbiota or hormonal balance, leading to excessive growth and subsequent infection. Therefore, it is essential to understand the characteristics of Candida albicans, its infection symptoms, and treatment methods.

• Types of Candidiasis Based on Infection Site
• Clinical Manifestations and Risk Factors
• Treatment Approaches and Prevention Strategies

Types of Candidiasis Based on Infection Site

There are several terms for candidiasis depending on the area of the body affected. Candidiasis occurring in the oral cavity is referred to as thrush. Oral candidiasis is the most common type of infection. The yeast responsible for this infection is Candida albicans, which is part of the normal oral microflora, and about 30–50% of individuals carry this organism. Under abnormal conditions, C. albicans infections can cause a wide spectrum of clinical manifestations, ranging from acute superficial infections to fatal disseminated diseases.

Clinical Manifestations and Risk Factors

Symptoms include white patches on the tongue, throat, and other parts of the mouth, often accompanied by pain and difficulty swallowing. This type of infection is caused by yeast invading the oral mucosa. Individuals with weakened immune systems or diabetes mellitus are more susceptible to Candida albicans infections. Complications may occur if the infection spreads to the trachea and esophagus, potentially leading to dysphagia and respiratory issues.

Meanwhile, candidiasis in the vagina is known as vulvovaginitis. This condition is also caused by Candida albicans and most commonly affects women of reproductive age. Symptoms include genital itching, a burning sensation, thick curd-like discharge, and swelling. 

Diagnosis is based on vaginal wet mount preparations and vaginal pH testing. If left untreated, this fungal infection can spread to other parts of the body and cause fever. About 90% of cases are caused by C. albicans, while most of the remaining cases are due to Candida glabrata. Risk factors include estrogen use, increased endogenous estrogen levels (during pregnancy or obesity), diabetes mellitus, HIV infection, and the use of broad-spectrum antibiotics.

Treatment Approaches and Prevention Strategies

Severe Candida infections can be treated with antifungal drugs such as nystatin, clotrimazole, amphotericin B, and miconazole. However, mild to moderate infections can be treated with antifungal vaginal creams, such as econazole, or oral fluconazole at a single 150 mg dose for 1, 3, or 7 days. This treatment can also be applied to oral thrush, but in a different form such as lozenges. 

Preventive measures include consuming oral probiotics or using vaginal probiotics to help balance the body’s microbiota, as well as adopting a healthy lifestyle by reducing excessive sugar intake, maintaining genital and oral hygiene, and managing stress. Candida albicans is part of the body’s normal microflora but can become an opportunistic pathogen under certain conditions. By understanding its characteristics, clinical symptoms, and appropriate treatment methods, individuals are expected to maintain good hygiene and adopt healthier lifestyles to prevent further complications.

Although Candida infections are very common, the effectiveness of treatment and the safety of a product still depend on the quality of its formulation. Many antifungal products are available, but not all have clear test data to prove their stability, active ingredient concentration, and antimicrobial activity. This is where laboratory testing plays a crucial role in ensuring the product truly works as claimed.

To ensure the quality and safety of the antifungal product you develop, you can consult with IML Research to determine the appropriate testing methods, from antifungal testing, microbial activity, to active ingredient quality, so your product can be more reliable and scientifically proven.

References:

Alomedika. (2023). Kandidiasis oral. Retrieved August 22, 2025, from https://www.alomedika.com/penyakit/telinga-hidung-tenggorokan/kandidiasis-oral
National Center for Biotechnology Information. (2021). Candidiasis. In StatPearls. StatPearls Publishing. Retrieved August 22, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK560624/